How to optimize an individualized strategy for antiplatelet drug administration and discontinuation management using platelet function testing?

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1761-2. doi: 10.1016/j.jtcvs.2014.05.011.

Authors

Ivan Burcar¹, Bojan Biocina¹, Josko Bulum², Mate Petricevic¹

Affiliations

¹ Department of Cardiac Surgery, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia.
² Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia.

PMID: 25260283
DOI: 10.1016/j.jtcvs.2014.05.011

No abstract available

Publication types

Letter
Comment

MeSH terms

Acute Coronary Syndrome / surgery*
Clopidogrel
Coronary Artery Bypass, Off-Pump*
Female
Humans
Male
Platelet Aggregation Inhibitors / therapeutic use*
Postoperative Hemorrhage / prevention & control*
Ticlopidine / analogs & derivatives*
Ticlopidine / therapeutic use

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine